| Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ... The Lancet Neurology 17 (12), 1053-1060, 2018 | 185 | 2018 |
| Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack: updated systematic review and meta-analysis G Ntaios, V Papavasileiou, D Sagris, K Makaritsis, K Vemmos, T Steiner, ... Stroke 49 (2), 412-418, 2018 | 132 | 2018 |
| Global impact of COVID-19 on stroke care and IV thrombolysis RG Nogueira, MM Qureshi, M Abdalkader, SO Martins, H Yamagami, ... Neurology 96 (23), e2824-e2838, 2021 | 124 | 2021 |
| COVID19 and ischemic stroke D Sagris, A Papanikolaou, A Kvernland, E Korompoki, JA Frontera, ... European journal of neurology 28 (11), 3826-3836, 2021 | 92 | 2021 |
| Recurrent ischemic stroke and bleeding in patients with atrial fibrillation who suffered an acute stroke while on treatment with nonvitamin K antagonist oral anticoagulants … M Paciaroni, V Caso, G Agnelli, MG Mosconi, M Giustozzi, DJ Seiffge, ... Stroke 53 (8), 2620-2627, 2022 | 40 | 2022 |
| Atrial fibrillation and stroke SE Choi, D Sagris, A Hill, GYH Lip, AH Abdul-Rahim Expert Review of Cardiovascular Therapy 21 (1), 35-56, 2023 | 39 | 2023 |
| Measurement of midregional pro-atrial natriuretic peptide to discover atrial fibrillation in patients with ischemic stroke J Schweizer, M Arnold, IR König, A Bicvic, LP Westphal, V Schütz, ... Journal of the American College of Cardiology 79 (14), 1369-1381, 2022 | 27 | 2022 |
| Antithrombotic treatment in cryptogenic stroke patients with patent foramen ovale: systematic review and meta-analysis D Sagris, G Georgiopoulos, K Perlepe, K Pateras, E Korompoki, ... Stroke 50 (11), 3135-3140, 2019 | 24 | 2019 |
| Atrial highrate episode duration thresholds and thromboembolic risk: a systematic review and metaanalysis D Sagris, G Georgiopoulos, K Pateras, K Perlepe, E Korompoki, ... Journal of the American Heart Association 10 (22), e022487, 2021 | 22 | 2021 |
| MgcRacGAP, a cytoskeleton regulator, inhibits HIF-1 transcriptional activity by blocking its dimerization A Lyberopoulou, I Mylonis, G Papachristos, D Sagris, A Kalousi, C Befani, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1833 (6), 1378-1387, 2013 | 22 | 2013 |
| Validation of the AF-ESUS score to identify patients with embolic stroke of undetermined source and low risk of device-detected atrial fibrillation A Kitsiou, D Sagris, WR Schäbitz, G Ntaios European Journal of Internal Medicine 89, 135-136, 2021 | 18 | 2021 |
| Carotid atherosclerosis and patent foramen ovale in embolic stroke of undetermined source G Ntaios, D Sagris, D Strambo, K Perlepe, G Sirimarco, G Georgiopoulos, ... Journal of Stroke and Cerebrovascular Diseases 30 (1), 105409, 2021 | 17 | 2021 |
| Interleukin-6 inhibitors reduce mortality in coronavirus disease-2019: An individual patient data meta-analysis from randomized controlled trials PT Tasoudis, CK Arvaniti, AT Adamou, I Belios, JH Stone, N Horick, ... European journal of internal medicine 101, 41-48, 2022 | 13 | 2022 |
| Intravenous thrombolysis after dabigatran reversal by idarucizumab: a systematic review of the literature S Frol, D Sagris, J Pretnar Oblak, M Šabovič, G Ntaios Frontiers in Neurology 12, 666086, 2021 | 13 | 2021 |
| Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation P Tiili, I Leventis, J Kinnunen, I Svedjebäck, M Lehto, E Karagkiozi, ... Annals of Medicine 53 (1), 1613-1620, 2021 | 13 | 2021 |
| Recommendations for lipid modification in patients with ischemic stroke or transient ischemic attack: a clinical guide by the Hellenic Stroke Organization and the Hellenic … D Sagris, G Ntaios, G Georgiopoulos, N Kakaletsis, M Elisaf, N Katsiki, ... International Journal of Stroke 16 (6), 738-750, 2021 | 12 | 2021 |
| Risk Factors for Intracerebral Hemorrhage in Patients With Atrial Fibrillation on Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention M Paciaroni, G Agnelli, M Giustozzi, V Caso, E Toso, F Angelini, ... Stroke 52 (4), 1450-1454, 2021 | 12 | 2021 |
| Proprotein Convertase Subtilisin-Kexin Type 9 inhibitors and stroke prevention: A meta-analysis D Sagris, G Ntaios, G Georgiopoulos, K Pateras, H Milionis European journal of internal medicine 85, 130-132, 2021 | 12 | 2021 |
| Bleeding risk comparison between direct oral anticoagulants at doses approved for atrial fibrillation and aspirin: systematic review, meta-analysis and meta-regression D Sagris, I Leventis, G Georgiopoulos, E Korompoki, K Makaritsis, ... European Journal of Internal Medicine 79, 31-36, 2020 | 11 | 2020 |
| 20-year trends of characteristics and outcomes of stroke patients with atrial fibrillation G Ntaios, D Sagris, F Gioulekas, P Galanis, C Pardali, A Vemmou, ... International Journal of Stroke 13 (7), 707-716, 2018 | 11 | 2018 |
George NtaiosDepartment of Internal Medicine, University of Thessaly, Larissa, Greece在 med.uth.gr 的电子邮件经过验证
